These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 11791959)
1. In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance. Noedl H; Wernsdorfer WH; Krudsood S; Wilairatana P; Viriyavejakul P; Kollaritsch H; Wiedermann G; Looareesuwan S Am J Trop Med Hyg; 2001 Dec; 65(6):696-9. PubMed ID: 11791959 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine. Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267 [TBL] [Abstract][Full Text] [Related]
3. Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam. Thanh NV; Cowman AF; Hipgrave D; Kim TB; Phuc BQ; Cong LD; Biggs BA Trans R Soc Trop Med Hyg; 2001; 95(5):513-7. PubMed ID: 11706663 [TBL] [Abstract][Full Text] [Related]
4. Drug-resistant malaria in Bangladesh: an in vitro assessment. Noedl H; Faiz MA; Yunus EB; Rahman MR; Hossain MA; Samad R; Miller RS; Pang LW; Wongsrichanalai C Am J Trop Med Hyg; 2003 Feb; 68(2):140-2. PubMed ID: 12641401 [TBL] [Abstract][Full Text] [Related]
5. Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study. Duraisingh MT; Jones P; Sambou I; von Seidlein L; Pinder M; Warhurst DC Parasitology; 1999 Nov; 119 ( Pt 5)():435-40. PubMed ID: 10599075 [TBL] [Abstract][Full Text] [Related]
6. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border. Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919 [TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil. Goldring JD; Padayachee T; Ismail I Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415 [TBL] [Abstract][Full Text] [Related]
8. [Combined antimalarial therapy using artemisinin]. Majori G Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Basco LK; Le Bras J Am J Trop Med Hyg; 1993 Sep; 49(3):301-7. PubMed ID: 8372953 [TBL] [Abstract][Full Text] [Related]
10. The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen. Al-Shamahy H; Al-Harazy AH; Harmal NS; Al-Kabsi AM Ann Saudi Med; 2007; 27(6):432-6. PubMed ID: 18059124 [TBL] [Abstract][Full Text] [Related]
12. Proposals for a new therapeutic strategy for simple Plasmodium falciparum malaria attacks in Cameroon. Louis JP; Hengy C; Louis FJ; Gazin P; Jambou R; Gardon J; Fadat G; Trebucq A Trop Med Parasitol; 1992 Jun; 43(2):118-20. PubMed ID: 1519023 [TBL] [Abstract][Full Text] [Related]
13. Antimalarial drug resistance and combination chemotherapy. White N Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):739-49. PubMed ID: 10365399 [TBL] [Abstract][Full Text] [Related]
14. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185 [TBL] [Abstract][Full Text] [Related]
15. Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine. Looareesuwan S; Kyle DE; Viravan C; Vanijanonta S; Wilairatana P; Charoenlarp P; Canfield CJ; Webster HK Am J Trop Med Hyg; 1992 Dec; 47(6):794-9. PubMed ID: 1471736 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials. Wongsrichanalai C; Nguyen TD; Trieu NT; Wimonwattrawatee T; Sookto P; Heppner DG; Kawamoto F Acta Trop; 1997 Feb; 63(2-3):151-8. PubMed ID: 9088428 [TBL] [Abstract][Full Text] [Related]
17. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850 [TBL] [Abstract][Full Text] [Related]
18. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Noedl H; Krudsood S; Leowattana W; Tangpukdee N; Thanachartwet W; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Yingyuen K; Sriwichai S; Ohrt C; Knirsch C Antimicrob Agents Chemother; 2007 Feb; 51(2):651-6. PubMed ID: 17116669 [TBL] [Abstract][Full Text] [Related]
19. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. Sidhu AB; Uhlemann AC; Valderramos SG; Valderramos JC; Krishna S; Fidock DA J Infect Dis; 2006 Aug; 194(4):528-35. PubMed ID: 16845638 [TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine. Alin MH Parasitology; 1997 Jun; 114 ( Pt 6)():503-6. PubMed ID: 9172420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]